NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 5.43 Million AUD | 2.74% |
| 2023 | 5.29 Million AUD | -31.62% |
| 2022 | 7.73 Million AUD | -47.82% |
| 2021 | 14.82 Million AUD | 296.7% |
| 2020 | 3.73 Million AUD | -27.05% |
| 2019 | 5.12 Million AUD | 533.37% |
| 2018 | 808.9 Thousand AUD | 39.72% |
| 2017 | 578.93 Thousand AUD | 134.79% |
| 2016 | 246.58 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 5.43 Million AUD | 0.0% |
| 2024 Q2 | 3.92 Million AUD | 0.0% |
| 2024 FY | 5.43 Million AUD | 2.74% |
| 2023 Q4 | 5.29 Million AUD | 0.0% |
| 2023 Q2 | 3.82 Million AUD | 0.0% |
| 2023 FY | 5.29 Million AUD | -31.62% |
| 2022 Q2 | 10.06 Million AUD | 0.0% |
| 2022 FY | 7.73 Million AUD | -47.82% |
| 2022 Q4 | 7.73 Million AUD | 0.0% |
| 2021 FY | 14.82 Million AUD | 296.7% |
| 2021 Q2 | 5.61 Million AUD | 0.0% |
| 2021 Q4 | 14.82 Million AUD | 0.0% |
| 2020 Q2 | 4.73 Million AUD | 0.0% |
| 2020 Q4 | 3.73 Million AUD | 0.0% |
| 2020 FY | 3.73 Million AUD | -27.05% |
| 2019 FY | 5.12 Million AUD | 533.37% |
| 2019 Q2 | 5.83 Million AUD | 0.0% |
| 2019 Q4 | 5.12 Million AUD | 0.0% |
| 2018 FY | 808.9 Thousand AUD | 39.72% |
| 2018 Q4 | 808.9 Thousand AUD | 0.0% |
| 2018 Q2 | 495.21 Thousand AUD | 0.0% |
| 2017 Q4 | 578.93 Thousand AUD | 0.0% |
| 2017 FY | 578.93 Thousand AUD | 134.79% |
| 2016 FY | 246.58 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | 2.461% |
| Acrux Limited | 8.96 Million AUD | 39.352% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 95.167% |
| BTC Health Limited | 5.14 Million AUD | -5.575% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 64.409% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 96.485% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 97.648% |
| Biome Australia Limited | 8.27 Million AUD | 34.324% |
| Hexima Limited | 2.26 Million AUD | -139.571% |
| Immutep Limited | 147.44 Million AUD | 96.313% |
| Memphasys Limited | 12.43 Million AUD | 56.269% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 97.808% |
| Noxopharm Limited | 6.78 Million AUD | 19.869% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 73.344% |
| Race Oncology Limited | 20.22 Million AUD | 73.128% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 92.454% |
| Starpharma Holdings Limited | 36.81 Million AUD | 85.234% |
| Tissue Repair Ltd | 19.38 Million AUD | 71.965% |
| Biotron Limited | 493.47 Thousand AUD | -1001.548% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 71.723% |
| CSL Limited | 56.93 Billion AUD | 99.99% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 78.726% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -225.224% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -72.044% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -4.87% |
| Patrys Limited | 4.16 Million AUD | -30.62% |
| Orthocell Limited | 26.61 Million AUD | 79.576% |
| Imugene Limited | 151.39 Million AUD | 96.41% |
| PYC Therapeutics Limited | 91.23 Million AUD | 94.042% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 50.015% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 35.197% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 59.082% |
| Nanollose Limited | 241.95 Thousand AUD | -2146.683% |
| Invex Therapeutics Ltd | 6.12 Million AUD | 11.179% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 63.383% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -111.969% |
| Nyrada Inc. | 5.9 Million AUD | 7.98% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 98.635% |
| Dimerix Limited | 32.07 Million AUD | 83.054% |
| PharmAust Limited | 11.12 Million AUD | 51.138% |
| AnteoTech Limited | 9.38 Million AUD | 42.056% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 80.154% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | 14.659% |
| Avecho Biotechnology Limited | 7.31 Million AUD | 25.732% |
| Actinogen Medical Limited | 21.31 Million AUD | 74.494% |
| Immuron Limited | 15.54 Million AUD | 65.043% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 66.809% |